Molecular Data Other Current Assets

The latest other current assets for MKD is $230M as of September 2021. Investors often review this figure alongside Molecular Data's historical trend and sector peers before judging valuation or financial health.

A other current assets figure of $230M for MKD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MKD's other current assets ($230M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Molecular Data's other current assets against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.